• CSIR launches ayurvedic anti-diabetic drug BGR-34 in Siliguri CSIR launches ayurvedic anti-diabetic drug BGR-34 in Siliguri

    07 Jul , 2016

    A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organisations for diabetes patients. The medicine named “BGR—34” has been developed jointly by CSIR—NBRI (National Botanical Research Institute) Lucknow and CSIR—CIMAP (Central Institute of Medicinal & Aromatic Plants (Lucknow). The medicine was launched in Siliguri at the presence of A K S Rawat—Principal Senior Scientist CSIR— National Botanical Research Institute,... A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organisations for diabetes patients. The medicine named “BGR—34” has been developed jointly by CSIR—NBRI (National Botanical Research Institute) Lucknow and CSIR—CIMAP (Central Institute of Medicinal & Aromatic Plants (Lucknow). The medicine was launched in Siliguri at the presence of A K S Rawat—Principal Senior Scientist CSIR— National Botanical Research Institute,...

    CONTINUE READING

  • Ayurvedic anti-diabetic drug launched in Coimbatore Ayurvedic anti-diabetic drug launched in Coimbatore

    05 Jul , 2016

    The Council for Scientific and Industrial Research (CSIR) launched here in Coimbatore BGR-34, billed as the country’s first anti-diabetic Ayurvedic drug with anti-hyperglycaemic property (reducing high blood sugar level). CSIR said BGR-34, meant for persons with Type 2 diabetes mellitus, had been scientifically validated for its efficacy and safety. It was developed jointly by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP), both research... The Council for Scientific and Industrial Research (CSIR) launched here in Coimbatore BGR-34, billed as the country’s first anti-diabetic Ayurvedic drug with anti-hyperglycaemic property (reducing high blood sugar level). CSIR said BGR-34, meant for persons with Type 2 diabetes mellitus, had been scientifically validated for its efficacy and safety. It was developed jointly by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP), both research...

    CONTINUE READING

  • Anti-Diabetic Medicine BGR-34 Launched In West Bengal Anti-Diabetic Medicine BGR-34 Launched In West Bengal

    07 Jun , 2016

    A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organisations for diabetes patients. The medicine named “BGR—34” has been developed jointly by CSIR—NBRI (National Botanical Research Institute) Lucknow and CSIR—CIMAP (Central Institute of Medicinal & Aromatic Plants (Lucknow). The medicine was launched in Kolkata at the presence of A K S Rawat—Principal Senior Scientist CSIR— National Botanical Research Institute,... A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organisations for diabetes patients. The medicine named “BGR—34” has been developed jointly by CSIR—NBRI (National Botanical Research Institute) Lucknow and CSIR—CIMAP (Central Institute of Medicinal & Aromatic Plants (Lucknow). The medicine was launched in Kolkata at the presence of A K S Rawat—Principal Senior Scientist CSIR— National Botanical Research Institute,...

    CONTINUE READING

  • CSIR launches ayurvedic anti-diabetic drug BGR-34 In Rest of Maharashtra CSIR launches ayurvedic anti-diabetic drug BGR-34 In Rest of Maharashtra

    02 Jun , 2016

    A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organisations for diabetes patients. The medicine named “BGR—34” has been developed jointly by CSIR—NBRI (National Botanical Research Institute) Lucknow and CSIR—CIMAP (Central Institute of Medicinal & Aromatic Plants (Lucknow). The medicine was launched in Rest of Maharashtra at the presence of A K S Rawat—Principal Senior Scientist CSIR— National Botanical... A low-cost Ayurvedic medicine has been developed by the Council for Scientific and Industrial Research (CSIR) along with two other organisations for diabetes patients. The medicine named “BGR—34” has been developed jointly by CSIR—NBRI (National Botanical Research Institute) Lucknow and CSIR—CIMAP (Central Institute of Medicinal & Aromatic Plants (Lucknow). The medicine was launched in Rest of Maharashtra at the presence of A K S Rawat—Principal Senior Scientist CSIR— National Botanical...

    CONTINUE READING

  • Affordable Ayurvedic Drug to Fight Diabetes Launched In Chennai: Priced At Rs 5 Affordable Ayurvedic Drug to Fight Diabetes Launched In Chennai: Priced At Rs 5

    29 May , 2016

    Council for Scientific and Industrial Research (CSIR) on 29 May launched in Chennai. BGR-34 - an anti-diabetic ayurvedic drug designed for type 2 Diabetes mellitus. BGR-34 is developed jointly by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP), the research units of CSIR at Lucknow. Aimed at managing type 2 diabetes, BGR-34 has been jointly developed by National Botanical Research Institute (NBRI) and Central... Council for Scientific and Industrial Research (CSIR) on 29 May launched in Chennai. BGR-34 - an anti-diabetic ayurvedic drug designed for type 2 Diabetes mellitus. BGR-34 is developed jointly by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP), the research units of CSIR at Lucknow. Aimed at managing type 2 diabetes, BGR-34 has been jointly developed by National Botanical Research Institute (NBRI) and Central...

    CONTINUE READING